Immunomagnetic separation for enrichment and sensitive detection of disseminated tumour cells in patients with head and neck SCC

Citation
M. Partridge et al., Immunomagnetic separation for enrichment and sensitive detection of disseminated tumour cells in patients with head and neck SCC, J PATHOLOGY, 189(3), 1999, pp. 368-377
Citations number
31
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research Diagnosis & Treatment
Journal title
JOURNAL OF PATHOLOGY
ISSN journal
00223417 → ACNP
Volume
189
Issue
3
Year of publication
1999
Pages
368 - 377
Database
ISI
SICI code
0022-3417(199911)189:3<368:ISFEAS>2.0.ZU;2-L
Abstract
Screening for malignant cells in the blood and bone marrow was introduced a s a strategy for the improved detection of tumour spread and may predict th e development of distant metastases. The sensitivity of these approaches de pends on several factors, including the choice of antibody for immunocytoch emistry (ICC) and the number of cells examined. In this study criteria have been defined for scoring cells reactive with a pan-cytokeratin antibody as tumour, by comparing immunostained cells in clinical samples obtained from head and neck cancer patients and a control group without epithelial malig nancy. When leucocyte subfractions are prepared by density gradient separat ion (DGS) from central venous blood obtained from patients with advanced he ad and neck squamous cell carcinoma (SCC) and screened by ICC, epithelial t umour cells sediment preferentially with the mononuclear cells but may also be detected in the granulocyte (GC) fraction, Some cases were found to hav e more tumour cells in the GC fraction. Similar results were seen in model experiments. To increase the sensitivity of the ICC approach, the efficienc y of positive immunomagnetic selection (IMS) using Dynabeads coated with an antibody recognizing the Ber/EP4 epitope has been compared with negative T MS using anti-CD45 Dynabeads. Tumour cells were recovered from bone marrow aspirates for 2/17 cases using the positive enrichment technique and for 11 /17 patients following negative IMS. These findings justify prospective stu dies incorporating negative IMS to establish the prognostic significance of these disseminated tumour cells for this group of patients. Copyright (C) 1999 John Wiley & Sons, Ltd.